Haemonetics Corporation (HAE) — Cash Flow Reinvestment Rate
Haemonetics Corporation (HAE) has a Cash Flow Reinvestment Rate of 0.25x as of March 2026, reinvesting $17.66 Million (capex $17.66 Million ) from operating cash flow of $70.94 Million. See Haemonetics Corporation free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Haemonetics Corporation Cash Flow Reinvestment Rate (1992–2026)
Historical reinvestment intensity for Haemonetics Corporation across 35 annual periods. For the full cash flow conversion analysis, see Haemonetics Corporation cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Haemonetics Corporation (1992–2026)
Year-by-year capital reinvestment analysis for Haemonetics Corporation. See Haemonetics Corporation (HAE) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.11x | $32.78 Million | $293.22 Million | $32.78 Million | ▼ -89.9% |
| 2025 | 1.11x | $201.17 Million | $181.72 Million | $39.28 Million | ▼ -48.2% |
| 2024 | 2.14x | $388.69 Million | $181.75 Million | $66.30 Million | ▲ +129.9% |
| 2023 | 0.93x | $253.98 Million | $273.06 Million | $110.19 Million | ▼ -12.4% |
| 2022 | 1.06x | $182.85 Million | $172.26 Million | $96.51 Million | ▼ -75.0% |
| 2021 | 4.25x | $462.48 Million | $108.81 Million | $37.04 Million | ▲ +534.8% |
| 2020 | 0.67x | $105.93 Million | $158.22 Million | $48.76 Million | ▼ -54.6% |
| 2019 | 1.48x | $235.11 Million | $159.28 Million | $118.96 Million | ▲ +136.0% |
| 2018 | 0.63x | $137.84 Million | $220.35 Million | $74.80 Million | ▼ -33.1% |
| 2017 | 0.94x | $149.45 Million | $159.74 Million | $76.14 Million | ▲ +8.2% |
| 2016 | 0.86x | $105.41 Million | $121.86 Million | $102.41 Million | ▼ -10.0% |
| 2015 | 0.96x | $122.22 Million | $127.18 Million | $122.22 Million | ▲ +61.2% |
| 2014 | 0.60x | $83.19 Million | $139.52 Million | $73.65 Million | ▼ -19.7% |
| 2013 | 0.74x | $63.19 Million | $85.07 Million | $62.19 Million | ▲ +61.0% |
| 2012 | 0.46x | $53.20 Million | $115.32 Million | $53.20 Million | ▲ +22.0% |
| 2011 | 0.38x | $46.67 Million | $123.45 Million | $46.67 Million | ▼ -12.3% |
| 2010 | 0.43x | $56.30 Million | $130.67 Million | $56.30 Million | ▼ -11.1% |
| 2009 | 0.48x | $56.38 Million | $116.36 Million | $56.38 Million | ▼ -34.9% |
| 2008 | 0.74x | $57.79 Million | $77.67 Million | $57.79 Million | ▲ +50.0% |
| 2007 | 0.50x | $41.46 Million | $83.56 Million | $41.46 Million | ▲ +15.5% |
| 2006 | 0.43x | $36.77 Million | $85.62 Million | $36.77 Million | ▲ +74.5% |
| 2005 | 0.25x | $17.53 Million | $71.21 Million | $17.53 Million | ▲ +32.5% |
| 2004 | 0.19x | $13.86 Million | $74.61 Million | $13.86 Million | ▼ -40.1% |
| 2003 | 0.31x | $13.54 Million | $43.67 Million | $13.54 Million | ▼ -53.7% |
| 2002 | 0.67x | $21.60 Million | $32.24 Million | $21.60 Million | ▲ +33.9% |
| 2001 | 0.50x | $30.54 Million | $61.01 Million | $30.54 Million | ▲ +14.8% |
| 2000 | 0.44x | $23.32 Million | $53.47 Million | $23.32 Million | ▼ -34.7% |
| 1999 | 0.67x | $22.50 Million | $33.70 Million | $22.50 Million | ▼ -33.2% |
| 1998 | 1.00x | $20.40 Million | $20.40 Million | $20.40 Million | ▼ -16.6% |
| 1997 | 1.20x | $32.00 Million | $26.70 Million | $32.00 Million | ▲ +233.4% |
| 1996 | 0.36x | $19.70 Million | $54.80 Million | $19.70 Million | ▼ -77.5% |
| 1995 | 1.60x | $24.90 Million | $15.60 Million | $24.90 Million | ▲ +88.2% |
| 1994 | 0.85x | $22.90 Million | $27.00 Million | $22.90 Million | ▲ +73.0% |
| 1993 | 0.49x | $17.60 Million | $35.90 Million | $17.60 Million | ▼ -19.2% |
| 1992 | 0.61x | $11.40 Million | $18.80 Million | $11.40 Million | — |